Dr. Emmett Mckenzie, MD

NPI: 1164502571
Total Payments
$8,312
2024 Payments
$45.77
Companies
3
Transactions
10

Payment Breakdown by Category

Other$5,950 (71.6%)
Travel$1,814 (21.8%)
Food & Beverage$548.16 (6.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,950 1 71.6%
Travel and Lodging $1,814 2 21.8%
Food and Beverage $548.16 7 6.6%

Top Paying Companies

Company Total Records Latest Year
Sumitomo Pharma America, Inc. $7,983 6 $0 (2023)
Endologix LLC $209.84 1 $0 (2021)
Abbott Laboratories $118.89 3 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $45.77 2 Abbott Laboratories ($45.77)
2023 $7,983 6 Sumitomo Pharma America, Inc. ($7,983)
2021 $209.84 1 Endologix LLC ($209.84)
2019 $73.12 1 Abbott Laboratories ($73.12)

All Payment Transactions

10 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/02/2024 Abbott Laboratories EPIC (Device) Food and Beverage In-kind items and services $23.82 General
Category: Structural Heart
07/15/2024 Abbott Laboratories EPIC (Device) Food and Beverage In-kind items and services $21.95 General
Category: Structural Heart
06/23/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,950.00 General
Category: CONGENITAL ATHYMIA
06/23/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Travel and Lodging Cash or cash equivalent $1,542.40 General
Category: CONGENITAL ATHYMIA
06/23/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Travel and Lodging Cash or cash equivalent $271.27 General
Category: CONGENITAL ATHYMIA
06/23/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Food and Beverage In-kind items and services $128.26 General
Category: CONGENITAL ATHYMIA
06/23/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Food and Beverage In-kind items and services $86.72 General
Category: CONGENITAL ATHYMIA
06/23/2023 Sumitomo Pharma America, Inc. RETHYMIC (Drug) Food and Beverage In-kind items and services $4.45 General
Category: CONGENITAL ATHYMIA
11/19/2021 Endologix LLC Food and Beverage In-kind items and services $209.84 General
06/28/2019 Abbott Laboratories HeartMate 3 Left Ventricular Dev (Device) Food and Beverage In-kind items and services $73.12 General
Category: Cardiac Arrhythmias and Heart Failure

About Dr. Emmett Mckenzie, MD

Dr. Emmett Mckenzie, MD is a Thoracic Surgery (Cardiothoracic Vascular Surgery) healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164502571.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emmett Mckenzie, MD has received a total of $8,312 in payments from pharmaceutical and medical device companies, with $45.77 received in 2024. These payments were reported across 10 transactions from 3 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($5,950).

Practice Information

Products in Payments

  • RETHYMIC (Drug) $7,983
  • HeartMate 3 Left Ventricular Dev (Device) $73.12
  • EPIC (Device) $45.77

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Thoracic Surgery (Cardiothoracic Vascular Surgery) Doctors in Houston